Epiminder Ltd. Stock Analysis EPI.AX
Epiminder Ltd. is a medical device and information solutions company, which focus on developing diagnostic and treatment tools for epilepsy. The company is headquartered in Melbourne, Victoria. The company went IPO on 2025-12-01. The Minder system is a minimally invasive device with equivalent form factors to a cochlear hearing device. The Minder Implant is a device placed under the scalp with several electrodes placed under the scalp, across the back of the head-this enables bilateral monitoring. Minder Wearable receives and stores EEG recordings wirelessly transmitted from the Minder Implant, then transfers this data wirelessly via low-power Bluetooth to the Minder App, running on a smartphone. The Minder App collects and transmits EEG data from the Minder Wearable via Bluetooth and uploads it to Minder Cloud for secure storage and processing. Minder Cloud offers a secure online portal that allows healthcare professionals to access and download patient data for viewing.
Read More Epiminder Ltd (EPI.AX) Chart
Key Statistics of Epiminder Ltd (EPI.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.45Volume
305.65KP/E Ratio (TTM)
-52 Week Range
Market Cap
98.10MAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of Epiminder Ltd (EPI.AX)
FAQ's for Epiminder Ltd (EPI.AX)
- According to Musaffa’s Shariah screening methodology, Epiminder Ltd (EPI.AX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.